Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Camphor/menthol OTC antitussive revised flammability warnings proposed.

This article was originally published in The Tan Sheet

Executive Summary

CAMPHOR/MENTHOL TOPICAL/INHALANT PRODUCTS REVISED BURN WARNING concerning the dangers of using the OTC antitussives near an open flame, in hot water or in a microwave oven are proposed by FDA as an amendment to the 1987 final monograph in a notice slated for publication in the July 20 Federal Register. The agency is basing the need for the revised warning on 34 reports of fire-related events between 1983 and mid-1997 that led to burns caused by flashing from the use of antitussives formulated with camphor and/or menthol. FDA is seeking comments on the proposal up to 90 days post-publication and estimates a 12-month implementation for the changes.

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts